ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

52
Analysis
Health CareAustralia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
bullishMayne Pharma
23 Feb 2025 02:18

Mayne Pharma (MYX AU): Cosette Pharma’s Binding Offer at A$7.40

The offer is reasonable but not a knockout bid. The vote is low-risk. At the last close and for an end-of-May payment, the gross/annualised spread...

Logo
580 Views
Share
bullishMayne Pharma
21 Feb 2025 09:43

Mayne Pharma (MYX AU): Cosette's A$7.40/Share Scheme

Clean deal. Trading tightish at 2.7%/10% gross/annualised spread, assuming early June completion. If in, stay in.  If small, illiquid arbs are your...

Logo
380 Views
Share
bullishTopcon Corp
01 Apr 2025 08:09

(Mostly) Asia M&A, Mar 2025 Wrap: ENN Energy, Gold Road, Spartan, Aeon Delight, Sinarmas, Topcon

For the month of March, 13 new deals were discussed on Smartkarma with an overall deal size of ~US$14bn. The average premium for the new deals...

Logo
246 Views
Share
bullishENN Energy
31 Mar 2025 01:18

Merger Arb Mondays (31 Mar) - ENN Energy, ESR, Vesync, Seven & I, Topcon, Sinarmas Land, Gold Road

We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
552 Views
Share
30 Mar 2025 06:15

(Mostly) Asia-Pac M&A: Gold Fields, Sinarmas Land, Shinko Electric, Domain, Japfa, Tsuruha/Welcia

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
315 Views
Share
x